Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

Abstract Background To conduct an indirect treatment comparison of patients with high-volume mHSPC and a cost analysis between Abi-ADT and Doc-ADT therapies in China. Methods The Bucher technique for indirect treatment comparison was used. A cost analysis was conducted from both healthcare and patie...

Full description

Bibliographic Details
Main Authors: Xin Hu, Shuli Qu, Xingxing Yao, Chaoyun Li, Yanjun Liu, Jianye Wang
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Prostate cancer
Docetaxel
Abiraterone
Cost analysis
Online Access:https://doi.org/10.1186/s12962-019-0193-4

Similar Items

Similar Items